Willard Dere, PhD
Dr. Willard Dere is Professor of Medicine, Executive Director of Personalized Health and Co-Director of Center for Clinical and Translational Science at the University of Utah. He is also a Board Member of BioMalin Pharmaceutical, Ocera Therapeutics and Radius Health. Besides being former Vice President of Eli Lilly, he was also Senior Vice President of Global Development at Amgen, where he was responsible for the clinical development of Raloxifene and other drugs for cancer, inflammation and kidney diseases. He holds an MD from University of California, Davis.

 

 

Arindam Bose, PhD
Dr. Arindam Bose has over 30 years of experience in the pharmaceutical industry and was elected to the National Academy of Engineering. As long-time consultant for bio-products R&D and manufacturing, he is committed to innovation in the manufacturing of biologics and serves professional social groups in the biopharmacy industry. He was former Project Leader, Executive Director and Vice President of External Affairs and Biosimilar Strategy of Pfizer, responsible for clinical and commercial manufacturing strategies. Dr. Bose is a member of The American Institute for Medical and Biological Engineering (AIMBE), The American Institute of Chemical Engineers (AIChE) and The American Chemical Society (ACS). He received his PhD from Purdue University.

 

Tse Wen Chang, PhD
Dr. Tse Wen Chang has over 40 years of experience spanning academia and industry. He founded Tanox and served as Vice President of R&D and a board member, focusing on developing new drugs based on antibody structure. He also discovered anti-IgE therapeutics, leading to the development of Xolair, a drug indicated for many IgE-mediated diseases. He acquired The World Academy of Sciences (TWAS) Prize in Medical Sciences and was selected as Honorary Fellow by the American College of Allergy, Asthma, and Immunology (ACAAI) twice. He received his PhD from Harvard University and was a Postdoctoral Fellow of MIT.

 

Dan Wu, PhD
Dr. Dan Wu is Tenured Professor of Pharmacology at Yale University. He carried out research of Signal Transduction at Caltech and Yale, publishing over 100 articles & reviews in top scientific journals including Nature and Cell. He has undertaken a total of 24 research projects, including 5 sponsored by the NIH. Dr. Wu received his PhD from Clarkson University.